Clinical Trial Update: Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas [Phase 1]

View source ↗

Summary

This is a completed Phase I trial evaluating an oral combination of topotecan and temozolomide for malignant gliomas, including glioblastoma, gliosarcoma, and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Hycamtin (Topotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Katy Peters | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED